Opening Brief Page3
Daiichi Sankyo has indicated it will also commence a prevention study with laninamivir – the current NDA relates to laninamivir as a treatment for flu.
So tell me if I'm wrong here but if all goes well laninamivir could replace annual flu shots given by your local GP.
- Forums
- ASX - By Stock
- BTA
- tamiflu resistance not the point here
tamiflu resistance not the point here, page-13
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online